---
title: 'State of the art and the future of microbiome-based biomarkers: a multidisciplinary
  Delphi consensus'
date: '2024-09-07'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39243797/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240908183632&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: Although microbiome signatures have been identified in various contexts
  (ie, pathogenesis of non-communicable diseases and treatment response), qualified
  microbiome-based biomarkers are currently not in use in clinical practice. The Human
  Microbiome Action consortium initiated a Delphi survey to establish a consensus
  on the needs, challenges, and limitations in developing qualified microbiome-based
  biomarkers. The questionnaire was developed by a scientific committee via literature
  review ...
disable_comments: true
---
Although microbiome signatures have been identified in various contexts (ie, pathogenesis of non-communicable diseases and treatment response), qualified microbiome-based biomarkers are currently not in use in clinical practice. The Human Microbiome Action consortium initiated a Delphi survey to establish a consensus on the needs, challenges, and limitations in developing qualified microbiome-based biomarkers. The questionnaire was developed by a scientific committee via literature review ...